These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16855381)

  • 1. Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella.
    Mengesha A; Dubois L; Lambin P; Landuyt W; Chiu RK; Wouters BG; Theys J
    Cancer Biol Ther; 2006 Sep; 5(9):1120-8. PubMed ID: 16855381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor hypoxia: a target for selective cancer therapy.
    Kizaka-Kondoh S; Inoue M; Harada H; Hiraoka M
    Cancer Sci; 2003 Dec; 94(12):1021-8. PubMed ID: 14662015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting solid tumors with non-pathogenic obligate anaerobic bacteria.
    Taniguchi S; Fujimori M; Sasaki T; Tsutsui H; Shimatani Y; Seki K; Amano J
    Cancer Sci; 2010 Sep; 101(9):1925-32. PubMed ID: 20579076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial delivery of the anti-tumor azurin-like protein Laz to glioblastoma cells.
    Mansour M; Ismail S; Abou-Aisha K
    AMB Express; 2020 Mar; 10(1):59. PubMed ID: 32221741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.
    Ryan RM; Green J; Williams PJ; Tazzyman S; Hunt S; Harmey JH; Kehoe SC; Lewis CE
    Gene Ther; 2009 Mar; 16(3):329-39. PubMed ID: 19177133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell mass-dependent expression of an anticancer protein drug by tumor-targeted
    Kim K; Min SY; Lim HD; You SH; Lim D; Jeong JH; Kim HJ; Rhee JH; Park K; Shin M; Kim GJ; Min JJ; Choy HE
    Oncotarget; 2018 Feb; 9(9):8548-8559. PubMed ID: 29492216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis.
    Ganai S; Arenas RB; Sauer JP; Bentley B; Forbes NS
    Cancer Gene Ther; 2011 Jul; 18(7):457-66. PubMed ID: 21436868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmable bacteria induce durable tumor regression and systemic antitumor immunity.
    Chowdhury S; Castro S; Coker C; Hinchliffe TE; Arpaia N; Danino T
    Nat Med; 2019 Jul; 25(7):1057-1063. PubMed ID: 31270504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic benefit of Salmonella attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility.
    Kocijancic D; Leschner S; Felgner S; Komoll RM; Frahm M; Pawar V; Weiss S
    Oncotarget; 2017 May; 8(22):36492-36508. PubMed ID: 28445131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy.
    Park SH; Zheng JH; Nguyen VH; Jiang SN; Kim DY; Szardenings M; Min JH; Hong Y; Choy HE; Min JJ
    Theranostics; 2016; 6(10):1672-82. PubMed ID: 27446500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors.
    Kim K; Jeong JH; Lim D; Hong Y; Lim HJ; Kim GJ; Shin SR; Lee JJ; Yun M; Harris RA; Min JJ; Choy HE
    Mol Ther Oncolytics; 2015; 2():15007. PubMed ID: 27119104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quorum-sensing Salmonella selectively trigger protein expression within tumors.
    Swofford CA; Van Dessel N; Forbes NS
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3457-62. PubMed ID: 25737556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth.
    Liu T; Chopra AK
    Cancer Gene Ther; 2010 Feb; 17(2):97-108. PubMed ID: 19713997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteria-driven nanosonosensitizer delivery system for enhanced breast cancer treatment through sonodynamic therapy-induced immunogenic cell death.
    Du M; Wang T; Peng W; Feng R; Goh M; Chen Z
    J Nanobiotechnology; 2024 Apr; 22(1):167. PubMed ID: 38610042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intelligent computation in cancer gene therapy.
    Samuel R; Daniel R
    Front Genet; 2024; 15():1252246. PubMed ID: 38549859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential.
    Luo M; Chen X; Gao H; Yang F; Chen J; Qiao Y
    Front Oncol; 2022; 12():980111. PubMed ID: 36276157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?
    Dicks LMT; Vermeulen W
    Microorganisms; 2022 Aug; 10(9):. PubMed ID: 36144335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered l-Lactate Responding Promoter System Operating in Glucose-Rich and Anoxic Environments.
    Zúñiga A; Camacho M; Chang HJ; Fristot E; Mayonove P; Hani EH; Bonnet J
    ACS Synth Biol; 2021 Dec; 10(12):3527-3536. PubMed ID: 34851606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors.
    Pierce KM; Miklavcic WR; Cook KP; Hennen MS; Bayles KW; Hollingsworth MA; Brooks AE; Pullan JE; Dailey KM
    Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835785
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Liu Q; Gai Y; Chen Y; Lan X; Jiang D
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.